URETERIC CANCER side effect
What is URETERIC CANCER ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
URETERIC CANCER and Recently Reported Side Effects
URETERIC CANCER and 15 most Active Side Effect polls
URETERIC CANCER and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Bleomycin Side Effects Report #5618786-7
Health Professional from JAPAN reported BLEOMYCIN SULPHATE problem on Feb 06, 2008. Male patient, 54 years of age, was diagnosed with testicular seminoma (pure) stage ii and was treated with BLEOMYCIN SULPHATE. After drug was administered, patient experienced the following problems/side effects: ureteric cancer, . BLEOMYCIN SULPHATE dosage: unknown. During the same period patient was treated with CISPLATIN, VINCRISTINE SULPHATE. Patient recovered.
Bleomycin Side Effects Report #5627236-6
BLEOMYCIN SULPHATE problem was reported by a Health Professional from JAPAN on Feb 14, 2008. Male patient, 54 years of age, was diagnosed with testicular seminoma (pure) stage ii and was treated with BLEOMYCIN SULPHATE. After drug was administered, patient experienced the following problems/side effects: ureteric cancer, . BLEOMYCIN SULPHATE dosage: unknown. During the same period patient was treated with CISPLATIN, VINCRISTINE SULPHATE. Patient recovered.
Remicade Side Effects Report #5394936-5
Physician from JAPAN reported REMICADE problem on July 12, 2007. Female patient, weighting 94.80 lb, was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: ureteric cancer, . REMICADE dosage: unknown. Patient was hospitalized. Patient recovered.
Remicade Side Effects Report #5401281-8
REMICADE problem was reported by a Physician from JAPAN on July 25, 2007. Female patient, weighting 94.80 lb, was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: ureteric cancer, . REMICADE dosage: unknown. Patient was hospitalized. Patient recovered.
Remicade Side Effects Report #5394936-5
Physician from JAPAN reported REMICADE problem on July 12, 2007. Female patient, weighting 94.80 lb, was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: ureteric cancer, . REMICADE dosage: unknown. Patient was hospitalized. Patient recovered.
Remicade Side Effects Report #5401281-8
REMICADE problem was reported by a Physician from JAPAN on July 25, 2007. Female patient, weighting 94.80 lb, was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: ureteric cancer, . REMICADE dosage: unknown. Patient was hospitalized. Patient recovered.
Prednisolone Side Effects Report #5678667-X
Physician from TURKEY reported PREDNISOLONE problem on Mar 11, 2008. Male patient, 34 years of age, was diagnosed with postoperative care, renal transplant and was treated with PREDNISOLONE. After drug was administered, patient experienced the following problems/side effects: peritoneal dialysis, ureteric cancer, . PREDNISOLONE dosage: 5 MG, DAILY,. During the same period patient was treated with TACROLIMUS, IMURAN. Patient recovered.
Avonex Side Effects Report #5520439-0
AVONEX problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 06, 2007. Female patient, 46 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: ureteric cancer, . AVONEX dosage: unknown. Patient recovered.
Evista Side Effects Report #5459962-6
Consumer or non-health professional from UNITED STATES reported EVISTA problem on Sept 04, 2007. Female patient was treated with EVISTA. After drug was administered, patient experienced the following problems/side effects: ureteric cancer, . EVISTA dosage: 60 MG, UNK. Patient recovered.
Crestor Side Effects Report #5255209-4
CRESTOR problem was reported by a Physician from UNITED KINGDOM on Feb 22, 2007. Female patient, weighting 188.5 lb, was diagnosed with cardiovascular event prophylaxis and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: hydronephrosis, ureteric cancer, . CRESTOR dosage: unknown. During the same period patient was treated with AMLODIPINE, DOXAZOSIN MESYLATE, TROSPIUM, CODYDRAMOL, VAGIFEM, MELOXICAM, LISINOPRIL. Patient was hospitalized. Patient recovered.